Prevalence of cutaneous warts in patients with systemic lupus erythematosus: a systematic review

被引:3
作者
Silva, Luisa Moreira [1 ]
Dourado Santos, Willer Goncalves [1 ]
Santiago, Mittermayer Barreto [1 ,2 ]
机构
[1] Escola Bahiana Med Saude Publ, Salvador, BA, Brazil
[2] Serv Especializados Reumatol Bahia, Rua Conde Filho 117, BR-40150150 Salvador, BA, Brazil
关键词
Cutaneous warts; Systemic lupus erythematosus; Immunosuppressive drugs; HPV; Human Papillomavirus; HUMAN-PAPILLOMAVIRUS INFECTION; VIRAL-INFECTIONS; ANTIBODIES; DIAGNOSIS; LESIONS;
D O I
10.3855/jidc.7947
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of this study was to review and evaluate systematically the scientific evidence on the relationship between systemic lupus erythematosus (SLE) and cutaneous warts (CW) caused by human papillomavirus (HPV) infection. With strict inclusion and exclusion criteria, we extensively searched the PUBMED, BVS (Virtual Health Library), and SCOPUS databases for the studies that evaluated the prevalence of CW in patients with SLE. Secondary references were additionally obtained from the selected articles. Only four articles met the research criteria and showed a higher frequency of CW in SLE patients compared to healthy controls. One of them highlighted about rheumatoid factor (RF) in the sera of patients with SLE and found an inverse correlation between the occurrence of warts and RF autoantibody. Moreover, most of the selected articles showed that the presence of CW did not correlate with the use of immunosuppressive drugs. Therefore, these findings suggest that the prevalence of CW in patients with SLE is probably high due to the defects in immune mechanisms, independently of immunosuppressive drugs.
引用
收藏
页码:902 / 906
页数:5
相关论文
共 20 条
[1]   Current Prevalence and Characteristics of Dermatoses Associated with Human Immunodeficiency Virus Infection [J].
Blanes, M. ;
Belinchon, I. ;
Merino, E. ;
Portilla, J. ;
Sanchez-Paya, J. ;
Betlloch, I. .
ACTAS DERMO-SIFILIOGRAFICAS, 2010, 101 (08) :702-709
[2]  
Cardoso JC, 2011, ACTA DERMATOVEN ALP, V20, P145
[3]  
Cojocaru Manole, 2011, Maedica (Bucur), V6, P330
[4]  
Harwood CA, 2000, J MED VIROL, V61, P289, DOI 10.1002/1096-9071(200007)61:3<289::AID-JMV2>3.0.CO
[5]  
2-Z
[6]   WARTS AND WART VIRUS-ANTIBODIES IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
JOHANSSON, E ;
PYRHONEN, S ;
ROSTILA, T .
BRITISH MEDICAL JOURNAL, 1977, 1 (6053) :74-76
[7]   Cutaneous warts in patients with lupus erythematosus [J].
Korkmaz, C ;
Ürer, SM .
RHEUMATOLOGY INTERNATIONAL, 2004, 24 (03) :137-140
[8]  
Loo SK, 2014, BMJ CLI EVID 0612
[9]   Prevalence of cervical human papillomavirus infection in women with systemic lupus erythematosus [J].
Lyrio, Leomar D. C. ;
Grassi, Maria Fernanda R. ;
Santana, Iuri U. ;
Olavarria, Viviana G. ;
Gomes, Aline do N. ;
CostaPinto, Licia ;
Oliveira, Rone Peterson C. ;
Aquino, Rita de Cassia R. ;
Santiago, Mittermayer B. .
RHEUMATOLOGY INTERNATIONAL, 2013, 33 (02) :335-340
[10]   STROBE initiative: guidelines on reporting observational studies [J].
Malta, Monica ;
Cardoso, Leticia Oliveira ;
Bastos, Francisco Inacio ;
Ferreira Magnanini, Monica Maria ;
Furtado Passos da Silva, Cosme Marcelo .
REVISTA DE SAUDE PUBLICA, 2010, 44 (03) :559-565